Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome

Thrombosis Research

Volumn 141, Issue , 2016, Pages S12-S16

  van Geffen, Johanna P ^a   Swieringa, Frauke ^a   Heemskerk, Johan W M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bleeding; phosphatidylserine; platelet; thrombin; thrombus

Indexed keywords

BLOOD CLOTTING FACTOR; CALCIUM; CALPAIN; FIBRIN; INTEGRIN; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBIN;

ARTICLE; BLOOD CLOT RETRACTION; BLOOD CLOTTING; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN LOCALIZATION; SCOTT SYNDROME; SWELLING; THROMBOCYTE FUNCTION; ANIMAL; BLOOD; BLOOD CLOTTING DISORDER; METABOLISM; PATHOLOGY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; PLATELET ACTIVATION; THROMBIN; THROMBOSIS;

EID: 84989915265     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(16)30355-3     Document Type: Article

References (70)

1. 1 Heemskerk, JW, Mattheij, N, Cosemans, JM, Platelet-based coagulation: different populations, different functions. J Thromb Haemost 11 (2013), 2–11.
2. 2 De Witt, SM, Verdoold, R, Cosemans, JM, Heemskerk, JW, Insights into platelet-based control of coagulation. Thromb Res 133 (2014), S139–S148.
3. 3 Broos, K, Feys, HB, De Meyer, SF, Vanhoorelbeke, K, Deckmyn, H, Platelets at work in primary hemostasis. Blood Rev 25 (2011), 155–167.
4. 4 Versteeg, HH, Heemskerk, JW, Levi, M, Reitsma, PH, New fundamentals in hemostasis. Physiol Rev 93 (2013), 327–358.
5. 5 Ruggeri, ZM, Platelets in atherothrombosis. Nat Med 8 (2002), 1227–1234.
6. 6 Schaff, M, Tang, C, Maurer, E, Bourdon, C, Receveru, N, Eckly, A, et al. Integrin a6b1 is the main receptor for vascular laminins and plays a role in platlet adhesion, activation, and arterial thrombosis. Circulation 128 (2013), 541–552.
7. 7 Mackman, N, Tilley, RE, Key, NS, Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 27 (2007), 1687–1693.
8. 8 Reininger, AJ, Bernlochner, I, Penz, SM, Ravanat, C, Smethurst, P, Farndale, RW, et al. A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques. J Am Coll Cardiol 55 (2010), 1147–1158.
9. 9 Van der Meijden, PE, Munnix, IC, Auger, JM, Govers-Riemslag, JW, Cosemans, JM, Kuijpers, MJ, et al. Dual role of collagen in factor XII-dependent thrombus formation. Blood 114 (2009), 881–890.
10. 10 Falati, S, Liu, Q, Gross, P, Merrill-Skoloff, G, Chou, J, Vandendries, E, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197 (2003), 1585–1598.
11. 11 Jackson, SP, Arterial thrombosis: insidious, unpredictable and deadly. Nat Med 17 (2011), 1423–1436.
12. 12 Auger, JM, Kuijpers, MJ, Senis, YA, Watson, SP, Heemskerk, JW, Adhesion of human and mouse platelets to collagen under shear: a unifying model. FASEB J 19 (2005), 825–827.
13. 13 Munnix, IC, Cosemans, JM, Auger, JM, Heemskerk, JW, Platelet response heterogeneity in thrombus formation. Thromb Haemost 102 (2009), 1149–1156.
14. 14 De Witt, SM, Swieringa, F, Cavill, R, Lamers, MM, van Kruchten, R, Mastenbroek, T, et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun, 5, 2014, 4257.
15. 15 Coughlin, SR, Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3 (2005), 1800–1814.
16. 16 Offermanns, S, Activation of platelet function through G protein-coupled receptors. Circ Res 99 (2006), 1293–1304.
17. 17 Bevers, EM, Comfurius, P, van Rijn, JL, Hemker, HC, Zwaal, RF, Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122 (1982), 429–436.
18. 18 Heemskerk, JW, Bevers, EM, Lindhout, T, Platelet activation and blood coagulation. Thromb Haemost 88 (2002), 186–193.
19. 19 Zwaal, RF, Scrambling membrane phospholipids and local control of blood clotting. News Int Physiol Sci 3 (1988), 57–61.
20. 20 Heemskerk, JW, Kuijpers, MJ, Munnix, IC, Siljander, PR, Platelet collagen receptors and coagulation. A characteristic platelet response as possible target for anti-thrombotic treatment. Trends Cardiovasc Med 15 (2005), 86–92.
21. 21 Agbani, EO, van den Bosch, MT, Brown, E, Williams, CM, Mattheij, NJ, Cosemans, JM, et al. Coordinated membrane ballooning and procoagulant spreading in human platelets. Circulation 132 (2015), 1414–1424.
22. 22 Welsh, JD, Stalker, TJ, Voronov, R, Muthard, RW, Tomaiuolo, M, Diamond, SL, et al. A systems approach to hemostasis: 1. The interdependence of thrombus architecture and agonist movements in the gaps between platelets. Blood 124 (2014), 1808–1815.
23. 23 Ono, A, Westein, E, Hsiao, S, Nesbitt, WS, Hamilton, JR, Schoenwaelder, SM, et al. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 112 (2008), 90–99.
24. 24 Van der Meijden, PE, Feijge, MA, Swieringa, F, Gilio, K, Nergiz-Unal, R, Hamulyak, K, et al. Key role of integrin αIIbβ3 signaling to Syk kinase in tissue factor-induced thrombin generation. Cell Mol Life Sci 69 (2012), 3481–3492.
25. 25 Cines, DB, Lebedeva, T, Nagaswami, C, Hayes, V, Massefski, W, Litvinov, RI, et al. Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. Blood 123 (2014), 1596–1603.
26. 26 Stalker, TJ, Traxler, EA, Wu, J, Wannemacher, KM, Cermignano, SL, Voronov, R, et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 121 (2013), 1875–1885.
27. 27 Cosemans, JM, Iserbyt, BF, Deckmyn, H, Heemskerk, JW, Multiple ways to switch platelet integrins on and off. J Thromb Haemost 6 (2008), 1253–1261.
28. 28 Mattheij, NJ, Gilio, K, van Kruchten, R, Jobe, SM, Wieschhaus, AJ, Chishti, AH, et al. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets. J Biol Chem 288 (2013), 13325–13336.
29. 29 Nurden, AT, Platelets, inflammation and tissue regeneration. Thromb Haemost 105:Suppl 1 (2011), S13–S33.
30. 30 Burkhart, JM, Gambaryan, S, Watson, SP, Jurk, K, Walter, U, Sickmann, A, et al. What can proteomics tell us about platelets?. Circ Res 114 (2014), 1204–1219.
31. 31 Puy, C, Tucker, EI, Wong, ZC, Gailani, D, Smith, SA, Choi, SH, et al. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates. J Thromb Haemost 11 (2013), 1341–1352.
32. 32 Deppermann, C, Cherpokova, D, Nurden, P, Schulz, JN, Thielmann, I, Kraft, P, et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest, 2013.
33. 33 Munnix, IC, Kuijpers, MJ, Auger, JM, Thomassen, CM, Panizzi, P, van Zandvoort, MA, et al. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation. Arterioscler Thromb Vasc Biol 27 (2007), 2484–2490.
34. 34 Cosemans, JM, Schols, SE, Stefanini, L, de Witt, S, Feijge, MA, Hamulyak, K, et al. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activation-dependent fibrin formation at low shear flow. Blood 117 (2011), 651–660.
35. 35 Berny, MA, Munnix, IC, Auger, JM, Schols, SE, Cosemans, JM, Panizzi, P, et al. Spatial distribution of factor Xa, thrombin, and fibrin(ogen) on thrombi at venous shear. Plos One, 5, 2010, e10415.
36. 36 Swieringa, F, Kuijpers, MJ, Lamers, MM, van der Meijden, PE, Heemskerk, JW, Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica 100 (2015), 748–756.
37. 37 Wielders, SJH, Broers, J, ten Cate, H, Collins, PW, Bevers, EM, Lindhout, T, Absence of platelet-dependent fibrin formation in a patient with Scott syndrome. Thromb Haemost 101 (2009), 76–82.
38. 38 Mosesson, MW, Fibrinogen and fibrin structure and functions. J Thromb Haemost 3 (2005), 1894–1904.
39. 39 Iino, M, Takeya, H, Takemitsu, T, Nakagaki, T, Gabazza, EC, Suzuki, K, Characterization of the binding of factor Xa to fibrinogen/fibrin derivatives and localization of the factor Xa binding site on fibrinogen. Eur J Biochem 232 (1995), 90–97.
40. 40 Konings, J, Govers-Riemslag, JW, Philippou, H, Mutch, NJ, Borissoff, JI, Allan, P, et al. Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood 118 (2011), 3942–3951.
41. 41 Miszta, A, Pelkmans, L, Lindhout, T, Krishnamoorthy, G, de Groot, PG, Hemker, HC, et al. Thrombin-dependent incorporation of von Willebrand factor into a fibrin network. J Biol Chem 289 (2014), 35979–35986.
42. 42 Gilbert, GE, Novakovic, VA, Shi, J, Rasmussen, J, Pipe, SW, Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine. Blood 126 (2015), 1237–1244.
43. 43 Ariens, RA, Lai, TS, Weisel, JW, Greenberg, CS, Grant, PJ, Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100 (2002), 743–754.
44. 44 Mitchell, JL, Lionikiene, AS, Fraser, SR, Whyte, CS, Functional factor XIII-A is exposed on the stimulated platelet surface. Blood 124 (2014), 3982–3990.
45. 45 Whyte, CS, Swieringa, F, Mastenbroek, TG, Lionikiene, AS, Lance, MD, van der Meijden, PE, et al. Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow. Blood 125 (2015), 2568–2578.
46. 46 Tsurupa, G, Medved, L, Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) alpha C-domains. Biochemistry 40 (2001), 801–808.
47. 47 Alberio, L, Safa, O, Clemetson, KJ, Esmon, CT, Dale, GL, Surface expression and functional characterization of a-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 95 (2000), 1694–1702.
48. 48 Mattheij, NJ, Swieringa, F, Mastenbroek, TG, Berny-Lang, MA, May, F, Baaten, CC, et al. Coated platelets function in fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII. Haematologica, 2016 in press.
49. 49 Alshehri, OM, Hughes, CE, Montague, S, Watson, SK, Frampton, J, Bender, M, et al. Fibrin activates GPVI in human and mouse platelets. Blood 126 (2015), 1601–1608.
50. 50 Mammadova-Bach, E, Ollivier, V, Loyau, S, Schaff, M, Dumont, B, Favier, R, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 126 (2015), 683–691.
51. 51 Kmit, A, van Kruchten, R, Ousingsawat, J, Mattheij, NJ, Senden-Gijsbers, B, Heemskerk, JW, et al. Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents. Cell Death Dis, 4, 2013, e611.
52. 52 Mattheij, NJ, Braun, A, van Kruchten, R, Castoldi, E, Pircher, J, Baaten, CC, et al. Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling and protein cleavage. FASEB J, 2016 in press.
53. 53 Suzuki, J, Umeda, M, Sims, PJ, Nagata, S, Calcium-dependent phospholipid scrambling by TMEM16F. Nature 468 (2010), 834–838.
54. 54 Van Kruchten, R, Mattheij, NJ, Saunders, C, Feijge, MA, Swieringa, F, Wolfs, JL, et al. Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation. Blood 121 (2013), 1850–1857.
55. 55 Misceo, D, Holmgren, A, Louch, WE, Holme, PA, Mizobuchi, M, Morales, RJ, et al. A dominant STIM1 mutation causes Stormorken syndrome. Hum Mutat 35 (2014), 556–564.
56. 56 Markello, T, Chen, D, Kwan, JY, Horkayne-Szakaly, I, Morrison, A, Simakova, O, et al. York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1. Mol Genet Metab 114 (2015), 474–482.
57. 57 Swieringa, F, Kuijpers, MJ, Heemskerk, JW, van der Meijden, PE, Targeting platelet receptor function in thrombus formation: the risk of bleeding. Blood Rev 28 (2014), 9–21.
58. 58 Roest, M, Reininger, A, Zwaginga, JJ, King, MR, Heemskerk, JW, Flow chamber-based assays to measure thrombus formation in vitro: requirements for standardization. J Thromb Haemost 9 (2011), 2322–2324.
59. 59 Van Kruchten, R, Cosemans, JM, Heemskerk, JW, Measurement of whole blood thrombus formation using parallel-plate flow chambers – a practical guide. Platelets 23 (2012), 229–242.
60. 60 Hathcock, JJ, Nemerson, Y, Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 104 (2004), 123–127.
61. 61 Colace, TV, Muthard, RW, Diamond, SL, Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow. Role of thrombin with and without fibrin. Arterioscler Thromb Vasc Biol 32 (2012), 1466–1476.
62. 62 Kuijpers, MJ, van der Meijden, PE, Feijge, MA, Mattheij, NJ, May, F, Govers-Riemslag, J, et al. Factor XIIa regulates the pathological process of thrombus formation on ruptured plaques. Arterioscler Thromb Vasc Biol 34 (2014), 1674–1680.
63. 63 Renné, T, Pozgajova, M, Grüner, S, Schuh, K, Pauer, HU, Burfeind, P, et al. Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202 (2005), 271–281.
64. 64 Schousboe, I, Nystrom, BT, Hansen, GH, Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin: localization of the Hep-1/Fib-1 binding site for activated factor XII. FEBS J 275 (2008), 5161–5172.
65. 65 White-Adams, TC, Berny, MA, Tucker, EI, Gertz, JM, Gailani, D, Urbanus, RT, et al. Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2). Arterioscler Thromb Vasc Biol 29 (2009), 1602–1607.
66. 66 Van Montfoort, ML, Kuijpers, MJ, Knaup, VL, Bhanot, S, Monia, BP, Roelofs, JT, et al. Inhibition of factor XI prevents pathological thrombus formation on acutely ruptured atherosclerotic plaques. Arterioscler Thromb Vasc Biol 34 (2014), 1668–1673.
67. 67 Mazzucato, M, Marco, LD, Masotti, A, Pradella, P, Bahou, WF, Ruggeri, ZM, Characterization of the initial alpha-thrombin interaction with glycoprotein Ib alpha in relation to platelet activation. J Biol Chem 273 (1998), 1880–1887.
68. 68 Hornyak, TJ, Shafer, JA, Interactions of factor XIII with fibrin as substrate and cofactor. Biochemistry 31 (1992), 423–429.
69. 69 Dale, GL, Friese, P, Batar, P, Hamilton, SF, Reed, GL, Jackson, KW, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415 (2002), 175–179.
70. 70 De Fouw, NJ, van Tilburg, NH, Haverkate, F, Bertina, RM, Activated protein C accelerates clot lysis by virtue of its anticoagulant activity. Blood Coagul Fibrinolysis 4 (1993), 201–210.